Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
Department of Dermatology, the First Affiliated Hospital of Fujian Medical University., Fuzhou, Fujian